ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 Published on July 2014
Report Summary Myoclonic Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, 'Myoclonic Seizures Global Clinical Trials Review, H2, 2014" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonic Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content Table of Contents Introduction 6 Myoclonic Seizures 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 1/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Clinical Trials by G7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Unaccomplished Trials of Myoclonic Seizures 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Myoclonic Seizures Therapeutics Clinical Trials 28 Prominent Drugs 29 Clinical Trial Profiles 30 Clinical Trial Overview of Top Companies 30 UCB S.A. 30 Clinical Trial Overview of UCB S.A. 30 Biocodex SA 31 Clinical Trial Overview of Biocodex SA 31 Teva Pharmaceutical Industries Limited 32 Clinical Trial Overview of Teva Pharmaceutical Industries Limited 32 Sky Growth Acquisition Corporation 33 Clinical Trial Overview of Sky Growth Acquisition Corporation 33 GW Pharmaceuticals plc 34 Clinical Trial Overview of GW Pharmaceuticals plc 34 Eisai Co., Ltd. 35 Clinical Trial Overview of Eisai Co., Ltd. 35 Desitin Arzneimittel GmbH 36 Clinical Trial Overview of Desitin Arzneimittel GmbH 36 Bluefish Pharmaceuticals AB 37 Clinical Trial Overview of Bluefish Pharmaceuticals AB 37 Adamed Sp. z o.o. 38 Clinical Trial Overview of Adamed Sp. z o.o. 38 Clinical Trial Overview of Top Institutes / Government 39 National Institute of Neurological Disorders and Stroke 39 Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 39 University of Colorado Denver 40 Clinical Trial Overview of University of Colorado Denver 40 Shizuoka University 41 Clinical Trial Overview of Shizuoka University 41 Institut National de la Sante et de la Recherche Medicale 42
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 2/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 42 University of Turku 43 Clinical Trial Overview of University of Turku 43 Five Key Clinical Profiles 44 Appendix 55 Abbreviations 55 Definitions 55 Research Methodology 56 Secondary Research 56 About GlobalData 57 Contact Us 57 Disclaimer 57 Source 57
List of Tables Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region, 2014* 7 Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10 Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13 Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14 Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15 Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16 Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17 Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18 Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19 Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase, 2014* 20 Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21 Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22 Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23 Myoclonic Seizures Therapeutics, Global, Terminated Clinical Trials, 2014* 24 Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25 Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26 Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27 Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28 Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 30 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocodex SA, 2014* 31 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 32 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Sky Growth Acquisition Corporation, 2014* 33 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 34 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 35 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014* 36 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 37
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 3/6
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamed Sp. z o.o., 2014* 38 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 39 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2014* 40 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka University, 2014* 41 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014* 42 Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turku, 2014* 43
List of Figures Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10 Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13 Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14 Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15 Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16 Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17 Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18 Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19 Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20 Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21 Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22 Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23 Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25 Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26 Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27 Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28 Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29 GlobalData Methodology 56
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 4/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Myoclonic Seizures Global Clinical Trials Review, H2, 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00
Quantity: _____
Site License--USD 5 000.00
Quantity: _____
Corporate License--USD 7 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 5/6
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Myoclonic Seizures Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 6/6